Back

Notification report


Full notification file


General information

Notification Number
B/ES/03/35

Member State to which the notification was sent
Spain

Date of acknowledgement from the Member State Competent Authority
14/02/2003

Title of the Project
Development of an Angiogenic Gene Therapy Product for Coronary Artery Disease.

Proposed period of release:
01/02/2003 to 31/07/2003

Name of the Institute(s) or Company(ies)
Schering Espana SA, ;


3. Is the same GMO release planned elsewhere in the Community?
Not known

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
Genus: Mastadenovirus
Species: human Adenovirus


Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
human serotype 5 (Ad5)Mastadenovirushuman adenovirussubgroup Chuman serotype 5 (Ad5)

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known